FSD Pharma Class Alpha and Beta Analysis
| HUGEDelisted Stock | USD 0.09 0 4.56% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as FSD Pharma Class. It also helps investors analyze the systematic and unsystematic risks associated with investing in FSD Pharma over a specified time horizon. Remember, high FSD Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to FSD Pharma's market risk premium analysis include:
Beta (1.15) | Alpha (0.89) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
FSD |
FSD Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. FSD Pharma market risk premium is the additional return an investor will receive from holding FSD Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in FSD Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate FSD Pharma's performance over market.| α | -0.89 | β | -1.15 |
FSD Pharma Fundamentals Vs Peers
Comparing FSD Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze FSD Pharma's direct or indirect competition across all of the common fundamentals between FSD Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as FSD Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of FSD Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare FSD Pharma to competition |
| Fundamentals | FSD Pharma | Peer Average |
| Return On Equity | -0.64 | -0.31 |
| Return On Asset | -0.34 | -0.14 |
| Current Valuation | 4.57 M | 16.62 B |
| Shares Outstanding | 46.06 M | 571.82 M |
| Shares Owned By Insiders | 9.74 % | 10.09 % |
| Shares Owned By Institutions | 2.81 % | 39.21 % |
| Number Of Shares Shorted | 176.97 K | 4.71 M |
FSD Pharma Opportunities
FSD Pharma Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Federal judge sides with FSD Pharma, confirms arbitration award owed by former CEO | 06/04/2024 |
2 | FSD Pharma provides Corporate Update HUGE Stock News - StockTitan | 06/28/2024 |
3 | 247 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma | 07/23/2024 |
4 | Why FSD Pharma Stock Is Seeing Huge Gains | 08/09/2024 |
5 | HUGE Stock Earnings FSD Pharma Misses EPS for Q2 2024 | 08/14/2024 |
About FSD Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including FSD or other delisted stocks. Alpha measures the amount that position in FSD Pharma Class has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
FSD Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of FSD Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, FSD Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of FSD Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of FSD Pharma. Please utilize our Beneish M Score to check the likelihood of FSD Pharma's management manipulating its earnings.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with FSD Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |